Results 11 to 20 of about 46,753 (257)

Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation

Obstetrics and Gynecology, 2021
The sequential use of mifepristone and misoprostol for termination of pregnancy after fetal death between 14 and 28 weeks of gestation reduces time to delivery compared with misoprostol alone.
E. Allanson, Sean Copson, K. Spilsbury, Sonya Criddle, B. Jennings, D. Doherty, Antonia M. Wong, J. Dickinson   +7 more
semanticscholar   +1 more source

Cost‐effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial

BJOG: an International Journal of Obstetrics and Gynaecology, 2021
To assess the cost‐effectiveness of mifepristone and misoprostol (MifeMiso) compared with misoprostol only for the medical management of a missed miscarriage.
C. Okeke Ogwulu, EV Williams, JJ Chu, A. Devall, Leanne Beeson, P. Hardy, V. Cheed, S. Yongzhong, LL Jones, JH La Fontaine Papadopoulos, R. Bender-Atik, J. Brewin, K. Hinshaw, M. Choudhary, A. Ahmed, J. Naftalin, N. Nunes, A. Oliver, F. Izzat, K. Bhatia, I. Hassan, Y. Jeve, J. Hamilton, S. Debs, C. Bottomley, J. Ross, L. Watkins, M. Underwood, Y. Cheong, Cs Kumar, P. Gupta, R. Small, S. Pringle, F. Hodge, A. Shahid, A. Horne, S. Quenby, I. Gallos, A. Coomarasamy, T. Roberts   +39 more
semanticscholar   +1 more source

The difference of Bishop score change and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks

Majalah Obstetri dan Ginekologi, 2023
HIGHLIGHTS • Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. • Oral misoprostol is as safe as vaginal misoprostol.   ABSTRACT Objective: To compare Bishop score changes and labor
Maskasoni Maskasoni, Julian Dewantiningrum   +1 more
doaj   +1 more source

Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. [PDF]

, 2020
BackgroundEarly pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg,
Atrio, Jessica M, Creinin, Mitchell D, Koelper, Nathanael, McAllister, Arden, Sammel, Mary D, Schreiber, Courtney A, Sonalkar, Sarita   +6 more
core   +1 more source

Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria

BMJ Open, 2020
Objectives This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria.
Melissa Stillman, O. Owolabi, A. Fatusi, A. Akinyemi, A. Berry, T. Erinfolami, O. Olagunju, Heini Väisänen, A. Bankole   +8 more
semanticscholar   +1 more source

Comparative Study of Oral and Vaginal Misoprostol for Induction of Labour, Maternal and Foetal Outcome [PDF]

Journal of Clinical and Diagnostic Research, 2013
Background: Misoprostol is a new promising agent for cervical ripening and induction of labour .The ideal dose, route and frequency of administration of misoprostol are still under investigation.
Kambhampati Komala, Meherlatha Reddy, Iqbal Jehan Quadri, Suneetha B., Ramya V.   +4 more
doaj   +1 more source

Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: Randomized controlled trial

PLoS ONE, 2020
Objective To compare effectiveness and safety of oral misoprostol (50 μg every four hours as needed), low dose vaginal misoprostol (25 to 50 μg every six hours as needed), and our established dinoprostone vaginal gel (one to two mg every six hours as ...
D. Young, D. Young, Tina Delaney, Tina Delaney, Tina Delaney, B. Armson, B. Armson, Cora A. Fanning, Cora A. Fanning   +8 more
semanticscholar   +1 more source

Intracervical Foley Catheter Plus Intravaginal Misoprostol vs Intravaginal Misoprostol Alone for Cervical Ripening: A Meta-Analysis

International Journal of Environmental Research and Public Health, 2020
Currently, there is no meta-analysis comparing intravaginal misoprostol plus intracervical Foley catheter versus intravaginal misoprostol alone for term pregnancy without identifying risk factors.
Howard Hao Lee, Ben Huang, Min Cheng, C. Yeh, I-Chia Lin, H. Horng, Hsin-Yi Huang, Wen-Ling Lee, Peng-Hui Wang   +8 more
semanticscholar   +1 more source

A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion

Journal of Family Medicine and Primary Care, 2023
Introduction: Misoprostol is widely used in the medical management of missed abortions. However, pretreatment with Mifepristone has shown to be effective but still not recommended to be used in missed abortions.
Nidhi Gupta, Reva Tripathi, Sumedha Sharma, Aruna Nigam, Sanjeet Panesar   +4 more
doaj   +1 more source

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi

BMC Pregnancy and Childbirth, 2020
Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality in low- and middle-income countries (LMICs). Oxytocin and misoprostol are used for the prevention and treatment of PPH. However, both medicines are chemically unstable and
Nhomsai Hagen, Felix Khuluza, L. Heide
semanticscholar   +1 more source